Skip to main content
TRDA logo

TRDA

Entrada Therapeutics, Inc.
$7.72 +0.13 (+1.71%) At close · Jul 2
Market Cap
$299.70M
Shares
38,820,616

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 118
Total Value: $319,011,098
Total Shares: 25,280,061
Showing 1–100 of 119 holdings by value · page 1 of 2

Institutional Ownership Trend

19 quarters

Holder Concentration

Across 118 13F filers
Top Holder
20.1%
Jun 2023 → Mar 2026 · range 15.9% – 20.7%
of institutional value
Top 5
59.5%
Jun 2023 → Mar 2026 · range 59.5% – 70.1%
of institutional value
Top 10
73.4%
Jun 2023 → Mar 2026 · range 73.4% – 88.3%
of institutional value
HHI
917
Jun 2023 → Mar 2026 · range 894 – 1,191
Broadly held
Showing 100 of 119
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1689375 CUSIP 29384C108 13F (30d) 2 filings 2 filers Visit website Investor relations